Total Payments
$10,522
2024 Payments
$1,532
Companies
53
Transactions
691
Medicare Patients
3,287
Medicare Billing
$200,340
Payment Breakdown by Category
Food & Beverage$10,522 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,522 | 691 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,619 | 118 | $0 (2024) |
| Novo Nordisk Inc | $1,550 | 116 | $0 (2024) |
| Lilly USA, LLC | $962.06 | 55 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $642.88 | 40 | $0 (2024) |
| Amarin Pharma Inc. | $545.01 | 35 | $0 (2023) |
| Amgen Inc. | $420.06 | 24 | $0 (2024) |
| Merck Sharp & Dohme LLC | $393.68 | 25 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $370.18 | 22 | $0 (2024) |
| Astellas Pharma US Inc | $346.75 | 23 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $320.51 | 19 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,532 | 87 | Novo Nordisk Inc ($400.09) |
| 2023 | $1,550 | 93 | AbbVie Inc. ($453.61) |
| 2022 | $1,602 | 103 | ABBVIE INC. ($376.28) |
| 2021 | $1,652 | 117 | AbbVie Inc. ($364.74) |
| 2020 | $1,241 | 90 | Novo Nordisk Inc ($250.16) |
| 2019 | $1,566 | 112 | Novo Nordisk Inc ($199.13) |
| 2018 | $1,353 | 87 | AstraZeneca Pharmaceuticals LP ($166.92) |
| 2017 | $26.08 | 2 | MERZ NORTH AMERICA, INC. ($26.08) |
All Payment Transactions
691 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: PAIN | ||||||
| 12/13/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: VACCINE | ||||||
| 12/10/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $23.56 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $7.77 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/26/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $8.72 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Cardio-renal | ||||||
| 11/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Obesity | ||||||
| 10/30/2024 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Respiratory | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: RESPIRATORY | ||||||
| 10/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: RESPIRATORY | ||||||
| 09/30/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Endocrinology | ||||||
| 09/23/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 843 | 1,214 | $98,750 | $52,129 |
| 2022 | 19 | 888 | 1,286 | $114,606 | $53,941 |
| 2021 | 20 | 784 | 1,269 | $105,122 | $50,985 |
| 2020 | 18 | 772 | 1,127 | $103,548 | $43,284 |
Total Patients
3,287
Total Services
4,896
Medicare Billing
$200,340
Procedure Codes
74
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 158 | 269 | $40,350 | $20,298 | 50.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 125 | 125 | $18,750 | $14,907 | 79.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 64 | 65 | $4,875 | $4,669 | 95.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 73 | 77 | $9,380 | $3,066 | 32.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 176 | 304 | $3,648 | $2,537 | 69.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 70 | 71 | $2,485 | $2,052 | 82.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $2,520 | $1,125 | 44.7% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 19 | 19 | $5,225 | $641.44 | 12.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 11 | 14 | $2,100 | $579.86 | 27.6% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 15 | 16 | $1,200 | $553.92 | 46.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 15 | 31 | $1,457 | $502.82 | 34.5% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 17 | 17 | $1,700 | $486.23 | 28.6% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 14 | 19 | $570.00 | $265.24 | 46.5% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 14 | 15 | $1,500 | $186.43 | 12.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 28 | 38 | $1,140 | $126.17 | 11.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 16 | 104 | $1,040 | $79.46 | 7.6% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 16 | 18 | $810.00 | $53.40 | 6.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 146 | 278 | $41,700 | $20,863 | 50.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 93 | 93 | $13,950 | $11,309 | 81.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 64 | 64 | $4,800 | $4,311 | 89.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 65 | 74 | $8,970 | $3,249 | 36.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $5,460 | $3,040 | 55.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 34 | 34 | $4,930 | $2,181 | 44.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 67 | 67 | $2,345 | $1,809 | 77.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 14 | 14 | $4,900 | $1,458 | 29.8% |
About Dr. Chad Turner, MD
Dr. Chad Turner, MD is a Family Medicine healthcare provider based in South Charleston, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245204510.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Chad Turner, MD has received a total of $10,522 in payments from pharmaceutical and medical device companies, with $1,532 received in 2024. These payments were reported across 691 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($10,522).
As a Medicare-enrolled provider, Turner has provided services to 3,287 Medicare beneficiaries, totaling 4,896 services with total Medicare billing of $200,340. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location South Charleston, WV
- Active Since 02/14/2006
- Last Updated 03/09/2018
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1245204510
Products in Payments
- Ozempic (Drug) $801.72
- UBRELVY (Drug) $563.45
- Vascepa (Drug) $545.01
- VRAYLAR (Drug) $518.78
- FARXIGA (Drug) $376.24
- QULIPTA (Drug) $372.73
- EVENITY (Biological) $304.63
- ELIQUIS (Drug) $294.66
- MOUNJARO (Drug) $291.60
- XARELTO (Drug) $265.66
- JARDIANCE (Drug) $255.03
- TRULICITY (Drug) $245.45
- MYRBETRIQ (Drug) $244.25
- XIFAXAN (Drug) $234.01
- ENTRESTO (Drug) $224.91
- Rybelsus (Drug) $224.10
- JANUVIA (Drug) $205.31
- TRADJENTA (Drug) $169.57
- Tresiba (Drug) $158.52
- APTIOM (Drug) $157.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in South Charleston
Dr. Julie Detemple, Md, MD
Family Medicine — Payments: $92,852
Family Medicine $92,852
Dr. Rohit Patel, M.d, M.D
Family Medicine — Payments: $26,815
Family Medicine $26,815
Joshua Bradford, Do, DO
Family Medicine — Payments: $18,789
Family Medicine $18,789
Michelle Burdette, Md, Retired, MD, RETIRED
Family Medicine — Payments: $12,269
Family Medicine $12,269
Dr. John Frame, D.o, D.O
Family Medicine — Payments: $8,656
Family Medicine $8,656
Howard Lafferty, Do, DO
Family Medicine — Payments: $7,233
Family Medicine $7,233